title: Recombinant human erythropoietin for the treatment of refractory anemia in lymphoproliferative disorders: preliminary results.
authors.forename: S t
authors.initials: St
authors.lastname: Tsiara
authors.forename: P
authors.initials: P
authors.lastname: Kaiafas
authors.forename: E
authors.initials: E
authors.lastname: Kapsali
authors.forename: L
authors.initials: L
authors.lastname: Christou
authors.forename: K L
authors.initials: KL
authors.lastname: Bourantas
mesh_terms: D000368:Aged; D000753:Anemia, Refractory / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications; D008232:Lymphoproliferative Disorders / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D008258:Waldenstrom Macroglobulinemia / Q000150:complications
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin